Prospective Study on the Feasibility and Results of POEM in Idiopathic Achalasia
POEM
1 other identifier
interventional
10
1 country
1
Brief Summary
Treatment options for achalasia include endoscopic dilations and surgical myotomy. Recently the POEM (Per oral endoscopic myotoymy) technique has been described. Patients undergo myotomy under endoscopic control. It has advantage over endoscopic dilation since myotomy is performed, and has advantage over surgery because it is performed endoscopically, thus is less invasive. One potential disadvantage in respect to surgery may be that it may determine higher rates of post-operative reflux. The purpose of this study is to prospectively assess the feasibility of PEOM in our Center with the new hybrid knife, and clinical results at 1, 3 and 12 months. This is a prospective, phase II study. Ten patients (age 18-75 years old) with diagnosis of achalasia, without megaesophagus or colonic esophagus, will be included for the POEM procedure. This study will last about 2 years. The aim is the feasibility, security and success rate of POEM for achalasia. Patients will be followed for at least one year.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Dec 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 29, 2014
CompletedFirst Posted
Study publicly available on registry
October 8, 2014
CompletedOctober 8, 2014
October 1, 2014
1.5 years
September 29, 2014
October 3, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Feasibility
Percentage of patients with successful POEM
24 months
Clinical Success
A reduction of 2 or more points in the Eckardt score, that determines a score of 3 or more in 24 months.
24 months
Secondary Outcomes (5)
Quality of Life
24 months
Adverse events
24 months
Reflux disease
24 months
Treatment failure
24 months
Efficacy
24 months
Study Arms (1)
Achalasia
EXPERIMENTALPatients (age 18-75 years old) with diagnosis of achalasia, without megaesophagus or colonic esophagus, will undergo POEM with the hybrid knife.
Interventions
POEM (Per oral endoscopic myotoymy) technique performed with the hybrid knife which combines injection and cutting in the same device.
Eligibility Criteria
You may qualify if:
- Age 18 to 75 years
- Manometric diagnosis of achalasia
- Eckardt score more than 3
- Informed consent
You may not qualify if:
- Increased surgical risk for important comorbidities,
- Pseudoachalasia
- Mega-esophagus (more than 7 cm) and or sigmoid esophagus,
- Previous esophageal or gastric surgery (with the exception of gastric perforation)
- Inability of completing the questionnarie
- Inability to keep a commitment for follow-up
- Esophageal diverticulum
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Endoscopy Unit, Humanitas Research Hospital
Rozzano, Milano, 20089, Italy
Related Publications (3)
Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992 Dec;103(6):1732-8. doi: 10.1016/0016-5085(92)91428-7.
PMID: 1451966BACKGROUNDInoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, Satodate H, Odaka N, Itoh H, Kudo S. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010 Apr;42(4):265-71. doi: 10.1055/s-0029-1244080. Epub 2010 Mar 30.
PMID: 20354937BACKGROUNDSwanstrom LL, Kurian A, Dunst CM, Sharata A, Bhayani N, Rieder E. Long-term outcomes of an endoscopic myotomy for achalasia: the POEM procedure. Ann Surg. 2012 Oct;256(4):659-67. doi: 10.1097/SLA.0b013e31826b5212.
PMID: 22982946BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alessandro Repici, MD
Istituto Clinico Humanitas
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of Clinical research Project
Study Record Dates
First Submitted
September 29, 2014
First Posted
October 8, 2014
Study Start
December 1, 2012
Primary Completion
June 1, 2014
Study Completion
September 1, 2014
Last Updated
October 8, 2014
Record last verified: 2014-10